These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 34207458)

  • 1. Novel Antivirals in Clinical Development for Chronic Hepatitis B Infection.
    Mak LY; Seto WK; Yuen MF
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34207458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drugs in Development for Hepatitis B.
    Dawood A; Abdul Basit S; Jayaraj M; Gish RG
    Drugs; 2017 Aug; 77(12):1263-1280. PubMed ID: 28660478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New antiviral targets for innovative treatment concepts for hepatitis B virus and hepatitis delta virus.
    Durantel D; Zoulim F
    J Hepatol; 2016 Apr; 64(1 Suppl):S117-S131. PubMed ID: 27084032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New antivirals for the treatment of chronic hepatitis B.
    Soriano V; Barreiro P; Benitez L; Peña JM; de Mendoza C
    Expert Opin Investig Drugs; 2017 Jul; 26(7):843-851. PubMed ID: 28521532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the developing pharmacotherapeutic landscape in hepatitis B treatment: a spotlight on drugs in phase II clinical trials.
    Hui RW; Mak LY; Seto WK; Yuen MF
    Expert Opin Emerg Drugs; 2022 Jun; 27(2):127-140. PubMed ID: 35511483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on hepatitis B virus infection.
    You CR; Lee SW; Jang JW; Yoon SK
    World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the multifunctional HBV core protein as a potential cure for chronic hepatitis B.
    Viswanathan U; Mani N; Hu Z; Ban H; Du Y; Hu J; Chang J; Guo JT
    Antiviral Res; 2020 Oct; 182():104917. PubMed ID: 32818519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for the treatment of hepatitis B.
    Fung J; Lai CL; Seto WK; Yuen MF
    Expert Opin Emerg Drugs; 2016 Jun; 21(2):183-93. PubMed ID: 26940510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent developments in antivirals against hepatitis B virus.
    Wang YJ; Yang L; Zuo JP
    Virus Res; 2016 Feb; 213():205-213. PubMed ID: 26732483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future anti-HBV strategies.
    Gane EJ
    Liver Int; 2017 Jan; 37 Suppl 1():40-44. PubMed ID: 28052637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B core protein as a therapeutic target.
    Mak LY; Wong DK; Seto WK; Lai CL; Yuen MF
    Expert Opin Ther Targets; 2017 Dec; 21(12):1153-1159. PubMed ID: 29065733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel targets for hepatitis B virus therapy.
    Testoni B; Durantel D; Zoulim F
    Liver Int; 2017 Jan; 37 Suppl 1():33-39. PubMed ID: 28052622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological Basis for the Cure of Chronic Hepatitis B.
    Hu J; Cheng J; Tang L; Hu Z; Luo Y; Li Y; Zhou T; Chang J; Guo JT
    ACS Infect Dis; 2019 May; 5(5):659-674. PubMed ID: 29893548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for immune modulation in achieving functional cure for chronic hepatitis B among current changes in the landscape of new treatments.
    Laupèze B; Vassilev V; Badur S
    Expert Rev Gastroenterol Hepatol; 2023; 17(11):1135-1147. PubMed ID: 37847193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upcoming pharmacological developments in chronic hepatitis B: can we glimpse a cure on the horizon?
    Alonso S; Guerra AR; Carreira L; Ferrer JÁ; Gutiérrez ML; Fernandez-Rodriguez CM
    BMC Gastroenterol; 2017 Dec; 17(1):168. PubMed ID: 29268704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Getting to HBV cure: The promising paths forward.
    Fung S; Choi HSJ; Gehring A; Janssen HLA
    Hepatology; 2022 Jul; 76(1):233-250. PubMed ID: 34990029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating the innate immune response to counter chronic hepatitis B virus infection.
    Lamb C; Arbuthnot P
    Expert Opin Biol Ther; 2016 Dec; 16(12):1517-1527. PubMed ID: 27603796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Monoclonal Antibodies as Adjuvant Treatment of Chronic Hepatitis B Virus Infection.
    Cerino A; Mantovani S; Mele D; Oliviero B; Varchetta S; Mondelli MU
    Front Immunol; 2019; 10():2290. PubMed ID: 31608071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus: new therapeutic perspectives.
    Lin CL; Yang HC; Kao JH
    Liver Int; 2016 Jan; 36 Suppl 1():85-92. PubMed ID: 26725903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emerging therapeutics and relevant targets for chronic Hepatitis B.
    Song IH
    Turk J Gastroenterol; 2016 May; 27(3):210-5. PubMed ID: 27210776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.